Differential DNA methylation of the p16 INK4A/CDKN2A promoter in human oral cancer cells and normal human oral keratinocytes

Oral Oncology

Volumn 35, Issue 5, 1999, Pages 516-522

  Cody II, D T ^a   Huang, Yuanhui ^a   Darby, C J ^a   Johnson, G K ^b   Domann, F E ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

AP 2; Cancer; CDKN2A; Cell cycle; DNA methylation; Gene; INK4A; p16; Tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE; DNA; PROTEIN P16;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MOUTH CANCER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; GENES, P16; HUMANS; KERATINOCYTES; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0032767550     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00026-3     Document Type: Article

References (18)

1. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:1993;704-707.
2. Ohtani-Fujita N., Fujita T., Aoike A., Osifchin N.E., Robbins P.D., Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene. 8:1993;1063-1067.
3. Harris L.C., Remack J.S., Brent T.P. In vitro methylation of the human O6-methylguanine-DNA methyltransferase promoter reduces transcription. Biochimica et Biophysica Acta. 1217:1994;141-146.
4. Ottaviano Y.L., Issa J.P., Parl F.F., Smith H.S., Baylin S.B., Davidson N.E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Research. 54:1994;2552-2555.
5. Fueyo J., Gomez-Manzano C., Bruner J.M.et al. Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas. Oncogene. 13:1996;1615-1619.
6. Lo K.W., Cheung S.T., Leung S.F.et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Research. 56:1996;2721-2725.
7. Ng M.H., Chung Y.F., Lo K.W., Wickham N.W., Lee J.C., Huang D.P. Frequent hypermethylation of p16 and pl5 genes in multiple myeloma. Blood. 89:1997;2500-2506.
8. Loughran O., Malliri A., Owens D.et al. Association of CDKN2A/p16 lNK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene. 13:1996;561-568.
9. Johnson G.K., Organ C.C. Prostaglandin E2 and interleukin-I concentrations in nicotine-exposed oral keratinocyte cultures. Journal of Periodontal Research. 32:1997;447-454.
10. Clark S.J., Harrison J., Paul C.L., Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Research. 22:1994;2990-2997.
11. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proceedings of National Academy of Science. 93:1996;9821-9826.
12. Bednarik D.P., Duckett C., Kim S.U.et al. DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs. New Biologist. 3:1991;969-976.
13. Comb M., Goodman H.M. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Research. 18:1990;3975-3982.
14. Huang Y., Peng J., Oberly L.W., Domann F.E. Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5′CpG island. Free Radical Biology and Medicine. 23:1997;314-320.
15. Hara E., Smith R., Parry D., Tahara H., Stone S., Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Molecular and Cellular Biology. 16:1996;859-867.
16. Imagawa M., Chiu R., Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and CAMP. Cell. 51:1987;251-260.
17. Williams T., Admon A., Luscher B., Tijian R. Cloning and expression of AP2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes and Development. 2:1988;1557-1569.
18. Luscher B., Mitchell P.J., Williams T., Tijian R. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes and Development. 3:1989;1507-1517.